| NDC Code | 43742-2193-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-2193-1) |
|---|
| Product NDC | 43742-2193 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Vir Combination |
|---|
| Non-Proprietary Name | Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 Dna, Herpes Simplex Virus 2 Dna, Epstein-barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6a, Human Herpesvirus 6b, Influenzinum (2023-2024) |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20240826 |
|---|
| End Marketing Date | 20300212 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Deseret Biologicals, Inc. |
|---|
| Substance Name | HEPATITIS B VIRUS; HERRING SPERM DNA; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE; INFLUENZA A VIRUS WHOLE; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE |
|---|
| Strength | 33; 12; 12; 15; 15; 16; 18; 15; 12; 12; 12; 12 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL |
|---|
| Pharmacy Classes | Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient] |
|---|